Jubilant Life Sciences raises ₹90 crore through commercial papers
1 min read 26 Nov 2020, 05:18 PM ISTTenure of the instrument is 53 days and date of maturity is January 18, 2021, Jubilant Life Sciences said in a regulatory filing
PremiumDrug firm Jubilant Life Sciences on Thursday said it has issued commercial papers worth ₹90 crore.
Tenure of the instrument is 53 days and date of maturity is January 18, 2021, Jubilant Life Sciences said in a regulatory filing.
Commercial paper is an unsecured money market instrument issued in the form of a promissory note. It was introduced in India in 1990 to enable highly rated corporate borrowers to diversify their sources of short-term borrowings and to provide an additional instrument to investors.
Shares of Jubilant Life Sciences closed at ₹719 per scrip on BSE, up 1.38% from its previous close.
This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.
Catch all the Corporate news and Updates on Live Mint.
Download The Mint News App to get Daily Market Updates & Live Business News.
More
Less
Updated: 26 Nov 2020, 05:18 PM IST
Next Story
×![]()
